Regeneron’s antibody drug shows protection against Covid-19 for up to 8 months
Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug’...